FIELD: medicine.
SUBSTANCE: method of treating inflammatory periodontal and oral mucosal diseases include the elimination of acute and inflammatory processes in the acute stage, elimination of supragingival and subgingival dental deposits, surgical and orthopedic intervention if there is evidence; oral irrigation with ozonated mineral water, optionally hydromassage, irrigation, instillation and irrigation on disease sites of periodontal tissue and oral mucosa is held with 3.5-2.5% solution of bentonite in warmed up to 38-42° C ozonized mineral water for 15-30 minutes daily for 10-14 days and it is taken inside twice a day in small sips to 100-150 ml for 14-21 days. Mineral water is used as mineral water, having the following composition: total mineralization - 1.9-2.5 g/dm3, hydrogen carbonate ions - 740-950 mg/dm3, sulfate ions - 90-140 mg/dm3, chloride ions - 500-600 mg/dm3, calcium ions - no more than 15 mg/dm3; magnesium ions - no more than 10 mg/dm3; ions of sodium and potassium - 600-800 mg/dm3, strontium - no more than 25.00 mg/dm3, chromium - not more than 0.50 mg/dm3, zinc - no more than 5.00 mg/dm3, lead - no more than 0.10 mg/dm3, mercury - not more than 0.02 mg/dm3, selenium - not more than 0.05 mg/dm3, vanadium - no more than 0.40 mg/dm3, copper - not more than 1.00 mg/dm3, cadmium - not more than 0.01 mg/dm3, nitrates - not more than 50.00 mg/dm3, nitrites - not more than 2.00 mg/dm3, fluorine - not more than 10.00 mg/dm3, arsenic - no more than 1.50 mg/dm3, phenols - not more than 0.10 mg/dm3, uranium - not more than 1.80 mg/dm3, radium - no more than 5.2×10-7 mg/dm3, organic substances in terms of carbon - 5.00-30.00 mg/dm3. In particular, mineral water can be used from the source of the resort of Saki, the Republic of Crimea, mineral water from the source of the resort of Loutraki, Greece, mineral water from the resort's source in Evpatoria, the Republic of Crimea. Montmorillonite clay Kudrinsky deposit, the Republic of Crimea can be used as bentonite.
EFFECT: effective treatment, reducing the risk of recurrence of inflammatory periodontal diseases and conditions after invasive interventions of the oral mucosa.
5 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PARODONTITIS | 2003 |
|
RU2254859C1 |
THERAPEUTIC-AND-PREVENTIVE TOOTHPASTE | 2018 |
|
RU2711246C1 |
METHOD FOR TREATMENT OF CHRONIC PERIODONTITIS | 2020 |
|
RU2751810C1 |
METHOD OF CHRONIC PERIODONTITIS TREATMENT | 2023 |
|
RU2810419C1 |
METHOD OF TREATING PERIODONTITIS | 2013 |
|
RU2519121C1 |
METHOD OF TREATING CHRONIC GENERALIZED PERIODONTITIS OF MILD AND MODERATE SEVERITY | 2019 |
|
RU2716637C1 |
METHOD OF TREATMENT PATIENTS WITH CHRONIC FORMS OF PERIODONTITIS AND PERIODONTITIS IN ACUTE PHASE | 2008 |
|
RU2393898C1 |
METHOD OF TREATING INFLAMMATORY DISEASES OF PARODONTIUM | 1996 |
|
RU2123319C1 |
METHOD FOR TREATING PAINFUL STATES IN THE MAXILLOFACIAL AREA | 2000 |
|
RU2177269C1 |
METHOD FOR TREATING DISEASES OF PARODONTIUM, PERIODONTIUM AND ORAL CAVITY MUCOSA | 2015 |
|
RU2613299C1 |
Authors
Dates
2018-01-25—Published
2016-05-31—Filed